Print this page
• Back to Web version of article
Index of Articles From 1997 Taglines
-
December, 1997
-
The Worldwide Epidemic: Global AIDS Picture Worsens
-
Global Infectious Causes of Death (Table)
-
The Future of AIDS (Table)
-
The Twilight of Eradication: Infectious HIV Persists After Up to 2 1/2 Years of Triple Drug Therapy
-
November, 1997
-
The FDA Decides the Fate of Two Drugs for AIDS-Related Malignancies
-
Three New Antivirals Trickle From the Pipeline
-
Hamburg Highlights
-
October, 1997
-
Republicans and Pharmaceutical Industry Target the FDA
-
Low Key Dual Combo Appears First to Achieve the Unimaginable
-
September, 1997
-
Would-Be Eradicatee Looks Forward to Still Uncertain Future
-
Data from the 23rd ACTG Meeting Document Reduction in Number of Opportunistic Infections in the Era of HAART
-
The Opportunistic Infections of ACTG 320 (Table)
-
August, 1997
-
Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance
-
Metabolic Disturbances in HIV Infection Find Friend Not Foe in Protease Inhibitor Regimens
-
How the Triple Combos Stack Up (Table)
-
June/July, 1997
-
May, 1997
-
April, 1997
-
March, 1997
-
February, 1997
-
January, 1997
Back to the Treatment Action Group index page
You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art39919.html
General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.